Frontiers in Cell and Developmental Biology (Dec 2024)
The protective role of gamma zone peripapillary atrophy in diabetic retinopathy: insights from deep learning and SS-OCT angiography
- Yingying Li,
- Yingying Li,
- Yingying Li,
- Yingying Li,
- Xinxin Hu,
- Xinxin Hu,
- Xinxin Hu,
- Xinxin Hu,
- Xueqiong Ye,
- Xueqiong Ye,
- Xueqiong Ye,
- Xueqiong Ye,
- Qingya Zhong,
- Qingya Zhong,
- Qingya Zhong,
- Qingya Zhong,
- Xixi Zhang,
- Xixi Zhang,
- Xixi Zhang,
- Xixi Zhang,
- Jinglin Zhu,
- Jinglin Zhu,
- Jinglin Zhu,
- Jinglin Zhu,
- Jiahui Jiang,
- Jiahui Jiang,
- Jiahui Jiang,
- Jiahui Jiang,
- Dandan Wang,
- Dandan Wang,
- Dandan Wang,
- Dandan Wang,
- Juntao Zhang,
- Juntao Zhang,
- Juntao Zhang,
- Juntao Zhang,
- Weina Ren,
- Weina Ren,
- Weina Ren,
- Weina Ren,
- Yitian Zhao,
- Qinkang Lu,
- Qinkang Lu,
- Qinkang Lu,
- Qinkang Lu,
- Na Zhao,
- Na Zhao,
- Na Zhao,
- Na Zhao
Affiliations
- Yingying Li
- Department of Ophthalmology, The Affiliated People’s Hospital of Ningbo University, Ningbo, China
- Yingying Li
- Ningbo Clinical Research Center for Ophthalmology, Ningbo, China
- Yingying Li
- Ningbo Key Laboratory for neuroretinopathy medical research, Ningbo, China
- Yingying Li
- Eye Hospital of Wenzhou Medical University (Ningbo Branch), Ningbo, China
- Xinxin Hu
- Department of Ophthalmology, The Affiliated People’s Hospital of Ningbo University, Ningbo, China
- Xinxin Hu
- Ningbo Clinical Research Center for Ophthalmology, Ningbo, China
- Xinxin Hu
- Ningbo Key Laboratory for neuroretinopathy medical research, Ningbo, China
- Xinxin Hu
- Eye Hospital of Wenzhou Medical University (Ningbo Branch), Ningbo, China
- Xueqiong Ye
- Department of Ophthalmology, The Affiliated People’s Hospital of Ningbo University, Ningbo, China
- Xueqiong Ye
- Ningbo Clinical Research Center for Ophthalmology, Ningbo, China
- Xueqiong Ye
- Ningbo Key Laboratory for neuroretinopathy medical research, Ningbo, China
- Xueqiong Ye
- Eye Hospital of Wenzhou Medical University (Ningbo Branch), Ningbo, China
- Qingya Zhong
- Department of Ophthalmology, The Affiliated People’s Hospital of Ningbo University, Ningbo, China
- Qingya Zhong
- Ningbo Clinical Research Center for Ophthalmology, Ningbo, China
- Qingya Zhong
- Ningbo Key Laboratory for neuroretinopathy medical research, Ningbo, China
- Qingya Zhong
- Eye Hospital of Wenzhou Medical University (Ningbo Branch), Ningbo, China
- Xixi Zhang
- Department of Ophthalmology, The Affiliated People’s Hospital of Ningbo University, Ningbo, China
- Xixi Zhang
- Ningbo Clinical Research Center for Ophthalmology, Ningbo, China
- Xixi Zhang
- Ningbo Key Laboratory for neuroretinopathy medical research, Ningbo, China
- Xixi Zhang
- Eye Hospital of Wenzhou Medical University (Ningbo Branch), Ningbo, China
- Jinglin Zhu
- Department of Ophthalmology, The Affiliated People’s Hospital of Ningbo University, Ningbo, China
- Jinglin Zhu
- Ningbo Clinical Research Center for Ophthalmology, Ningbo, China
- Jinglin Zhu
- Ningbo Key Laboratory for neuroretinopathy medical research, Ningbo, China
- Jinglin Zhu
- Eye Hospital of Wenzhou Medical University (Ningbo Branch), Ningbo, China
- Jiahui Jiang
- Department of Ophthalmology, The Affiliated People’s Hospital of Ningbo University, Ningbo, China
- Jiahui Jiang
- Ningbo Clinical Research Center for Ophthalmology, Ningbo, China
- Jiahui Jiang
- Ningbo Key Laboratory for neuroretinopathy medical research, Ningbo, China
- Jiahui Jiang
- Eye Hospital of Wenzhou Medical University (Ningbo Branch), Ningbo, China
- Dandan Wang
- Department of Ophthalmology, The Affiliated People’s Hospital of Ningbo University, Ningbo, China
- Dandan Wang
- Ningbo Clinical Research Center for Ophthalmology, Ningbo, China
- Dandan Wang
- Ningbo Key Laboratory for neuroretinopathy medical research, Ningbo, China
- Dandan Wang
- Eye Hospital of Wenzhou Medical University (Ningbo Branch), Ningbo, China
- Juntao Zhang
- Department of Ophthalmology, The Affiliated People’s Hospital of Ningbo University, Ningbo, China
- Juntao Zhang
- Ningbo Clinical Research Center for Ophthalmology, Ningbo, China
- Juntao Zhang
- Ningbo Key Laboratory for neuroretinopathy medical research, Ningbo, China
- Juntao Zhang
- Eye Hospital of Wenzhou Medical University (Ningbo Branch), Ningbo, China
- Weina Ren
- Department of Ophthalmology, The Affiliated People’s Hospital of Ningbo University, Ningbo, China
- Weina Ren
- Ningbo Clinical Research Center for Ophthalmology, Ningbo, China
- Weina Ren
- Ningbo Key Laboratory for neuroretinopathy medical research, Ningbo, China
- Weina Ren
- Eye Hospital of Wenzhou Medical University (Ningbo Branch), Ningbo, China
- Yitian Zhao
- Laboratory of Advanced Theranostic Materials and Technology, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo, China
- Qinkang Lu
- Department of Ophthalmology, The Affiliated People’s Hospital of Ningbo University, Ningbo, China
- Qinkang Lu
- Ningbo Clinical Research Center for Ophthalmology, Ningbo, China
- Qinkang Lu
- Ningbo Key Laboratory for neuroretinopathy medical research, Ningbo, China
- Qinkang Lu
- Eye Hospital of Wenzhou Medical University (Ningbo Branch), Ningbo, China
- Na Zhao
- Department of Ophthalmology, The Affiliated People’s Hospital of Ningbo University, Ningbo, China
- Na Zhao
- Ningbo Clinical Research Center for Ophthalmology, Ningbo, China
- Na Zhao
- Ningbo Key Laboratory for neuroretinopathy medical research, Ningbo, China
- Na Zhao
- Eye Hospital of Wenzhou Medical University (Ningbo Branch), Ningbo, China
- DOI
- https://doi.org/10.3389/fcell.2024.1501625
- Journal volume & issue
-
Vol. 12
Abstract
PurposeTo explore the relationship between peripapillary atrophy (PPA) and diabetic retinopathy (DR), and to uncover potential mechanisms using swept-source optical coherence tomography (SS-OCT) angiography.MethodsThis cross-sectional study included 845 patients with type 2 diabetes (T2DM), who underwent detailed systemic and ophthalmic evaluations. A state-of-the-art deep learning method was employed to precisely identify the parapapillary beta and gamma zones. Based on PPA characteristics, eyes were categorized into four groups: without beta or gamma zone (Group A), isolated beta zone (Group B), isolated gamma zone (Group C), and with both beta and gamma zone (Group D). Digital fundus photography was utilized to diagnose and stage DR severity, while SS-OCT angiography quantified retinal and choroidal vasculature.ResultsParticipants had a mean age of 66 ± 8.8 years, with 437 (51.7%) male. Beta and gamma PPA zones were observed in 574 (67.9%) and 256 (30.3%) eyes, respectively. Beta zone PPA was associated with older age, whereas gamma zone PPA was correlated with longer axial length (AL), lower vessel density, and reduced choroidal thickness. Adjusted analyses revealed that eyes with isolated (Group C) or concurrent (Group D) gamma zone PPA conferred significantly lower DR grade, independent of known risk factors including systemic diabetes risk factors and AL.ConclusionThis study finds that gamma zone PPA is linked to a reduced risk of developing DR. These results imply that the gamma zone may reflect progressive myopia-associated thinning and microvascular depletion in posterior ocular tissues, potentially contributing to structural resilience against DR. This novel insight offers a promising avenue for understanding the interplay between PPA and DR.
Keywords
- gamma zone
- peripapillary atrophy
- diabetic retinopathy
- deep learning
- optical coherence tomography angiography